ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,160Medicare Part D Prescriptions Filled, Including Refills

Rank: 319 out of 1107

$359K Total Retail Price of All Prescriptions

Rank: 535 out of 1107

492 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 492 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 492 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 9,058 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$35 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
OMEPRAZOLE 373 338 1 4
FUROSEMIDE 365 343 2 7
GABAPENTIN 342 269 3 9
SIMVASTATIN 333 309 4 5
PRAVASTATIN SODIUM 331 302 5 12
LEVOTHYROXINE SODIUM 299 272 6 3
AMLODIPINE BESYLATE 233 199 7 6
HYDROCODONE-ACETAMINOPHEN 226 185 S3 8 1
POTASSIUM CHLORIDE 223 212 9 14
METOPROLOL TARTRATE 218 207 10 10
METOPROLOL SUCCINATE 195 193 11 16
WARFARIN SODIUM 195 150 11 15
LISINOPRIL 177 148 13 2
RANITIDINE HCL 166 153 14 21
METFORMIN HCL 153 123 15 8
LISINOPRIL-HYDROCHLOROTHIAZIDE 143 127 16 24
POLYETHYLENE GLYCOL 3350 141 130 17 46
SERTRALINE HCL 137 137 18 20
METFORMIN HCL ER 135 105 19 58
CITALOPRAM HBR 134 121 20 17
LOSARTAN-HYDROCHLOROTHIAZIDE 132 127 21 66
ISOSORBIDE MONONITRATE ER 126 125 22 34
GLIMEPIRIDE 118 105 23 43
DIGOXIN 114 108 24 52
HYDROCHLOROTHIAZIDE 109 101 25 11
CARVEDILOL 103 94 26 27
AZITHROMYCIN 103 89 26 35
CEPHALEXIN 101 86 28 81
LOSARTAN POTASSIUM 97 86 29 29
TAMSULOSIN HCL 90 78 30 30
ALLOPURINOL 88 81 31 36
RISPERIDONE 86 84 32 79
LEVOFLOXACIN 84 78 33 71
KLOR-CON 10 83 82 34 143
CLOPIDOGREL 83 75 34 28
PROAIR HFA 82 62 36 37
ZOLPIDEM TARTRATE 79 79 37 22
ATENOLOL 75 66 38 19
KLOR-CON M20 72 63 39 75
CIPROFLOXACIN HCL 71 66 40 59
NEXIUM 70 43 41 18
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 55 42 88
DONEPEZIL HCL 63 63 43 32
NYSTATIN 62 62 44 110
KLOR-CON M10 62 56 44 159
PAROXETINE HCL 61 35 46 45
TRAMADOL HCL 61 52 46 26
PREDNISONE 60 60 48 40
FLUOXETINE HCL 55 37 49 47
GLIPIZIDE 53 53 50 64
SYNTHROID 51 51 51 70
TRIAMTERENE-HCTZ 50 50 52 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.